Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.37 |
| ▸ | PDCD1 | Q15116 | 9/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 9/20 | 0.36 |
| ▸ | PDE6D | O43924 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19843475 | 0.97 | TYMS (0.45) | TYMSALDH1A1NR1H2PDCD1CD274 | |
| SCHEMBL23476539 | 0.95 | TYMS (0.44) | TYMSALDH1A1NR1H2PDCD1CD274 | |
| SCHEMBL19842959 | 0.92 | TYMS (0.42) | TYMSALDH1A1NR1H2PDCD1CD274 | |
| SCHEMBL19843465 | 0.92 | TYMS (0.47) | TYMSALDH1A1NR1H2PDCD1CD274 | |
| SCHEMBL19843608 | 0.92 | TYMS (0.45) | TYMSALDH1A1NR1H2PDCD1CD274 | |
| SCHEMBL19843464 | 0.92 | TYMS (0.45) | TYMSALDH1A1NR1H2PDCD1CD274 | |
| SCHEMBL23476492 | 0.91 | TYMS (0.41) | TYMSALDH1A1NR1H2PDCD1CD274 | |
| SCHEMBL19843330 | 0.91 | TYMS (0.42) | TYMSALDH1A1NR1H2PDCD1CD274 | |
| SCHEMBL19842696 | 0.90 | TYMS (0.42) | TYMSALDH1A1PDE6DHTTHPSE | |
| SCHEMBL19843554 | 0.90 | PDE6D (0.44) | TYMSALDH1A1PDE6DHTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3494112-B1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2022-04-20 | — | — | EP | disclosed |
| US-20210171501-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
| WO-2018024725-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-02-08 | — | — | WO | disclosed |
| EP-3279194-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171501-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | L1CAM, OR10J3, AOX1 | TYMS 2154/4885ALDH1A1 20/4885NR1H2 2382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.